Company intelligence
DICE-CRO
Making biotech and pharma companies succeed
About DICE-CRO
DICE is a Contract Research Organization with over 35 years of experience in the design and execution of clinical trials. Our mission is to make biotech and pharma companies succeed. We have designed and executed over 1250 clinical studies, mainly phase I to III studies, who were part of clinical development programs aimed at obtaining MA in the US and Europe. Our services are: - Clinical study design - Biostatistics - Statistical programming - Clinical data management - Data standardization (CDISC) - Medical writing - Central imaging review - Medical monitoring DICE has over 80% of recurring business as we stand for: 1. In depth experience of guidelines and hands-on knowledge on how to implement these guidelines 2. Making the complex easy: we focus on what matters for our customers 3. Tailored solutions to our customers needs Our knowledgeable and dedicated team of experts have a drive and curiosity that encourages them to take on projects as if they were their own. At DICE, your success is our own success. For more information, visit www.dice-cro.com or email bd@dice-cro.com
Verified activity
Signals from DICE-CRO
4 published signals
Presence & Recognition
DICE-CRO is heading to Boston from 21 to 24 September to join the Belgian trade mission to the US with BIOVIA, VIB, FIT - Flanders Investment & Trade, and Alumni: Advanced Master in Biotech & MedTech Ventures.
Reported by DICE-CRO
Research & Knowledge
DICE-CRO and Tufts CSDD and TransCelerate looked at what all that collecting actually delivers in Phase III pivotal studies, procedures up 40% over the past decade, and data points up 283%
Reported by DICE-CRO
Presence & Recognition
DICE-CRO and Tufts CSDD and TransCelerate looked at what all that collecting actually delivers in Phase III pivotal studies, procedures up 40% over the past decade, and data points up 283%
Reported by DICE-CRO
Presence & Recognition
DICE-CRO and Tufts CSDD and TransCelerate are hosting a trade mission to Boston with BIOVIA, VIB, FIT - Flanders Investment & Trade, and Alumni: Advanced Master in Biotech & MedTech Ventures later this month
Reported by DICE-CRO